Unilife and Flextronics Enter Into Global Strategic Alliance

YORK, Pa., Nov. 13, 2014 /PRNewswire/ -- Unilife Corporation UNISUNS, a designer, manufacturer and supplier of injectable drug delivery systems, today announced the signing of a Global Strategic Alliance Agreement with Flextronics FLEX, a leading end-to-end supply chain solutions company, as its global strategic partner to further expand the production capacity and scale-up capability of Unilife's product portfolio.

The Global Strategic Alliance Agreement between Unilife and Flextronics will support accelerating commercial demand from a multitude of pharmaceutical customers who are seeking to leverage Unilife's products and services to enhance and differentiate their injectable biologics, drugs and vaccines.  In addition to Unilife fully utilizing its own FDA-registered manufacturing facilities in York, Pennsylvania, Flextronics will serve as a secondary source of supply to Unilife and its pharmaceutical customers.

Dr. Ramin Mojdeh, President and Chief Operating Officer of Unilife, said: "This strategic alliance will further enhance our supply chain and maximize efficiencies by aligning our own production capacity and scale-up capability with Flextronics' proven manufacturing expertise and established global size.  Flextronics is a leading and trusted provider of supply chain solutions for the pharmaceutical industry, and has long-term relationships with many current and prospective Unilife customers. We look forward to leveraging the power of Flextronics and their global manufacturing capabilities to further enhance Unilife's own supply chain network and generate attractive manufacturing and supply chain efficiencies and robustness. Additionally, this partnership allows for the most efficient capital investment strategy to support our rapidly growing demand."

"Flextronics is proud to collaborate and provide supply chain solutions to Unilife," said Mark Kemp, president of Flextronics Medical.  "We believe Unilife has created an exciting product portfolio that has significant potential to optimize the safe, simple and convenient delivery of injectable biologics, drugs and vaccines. We look forward to aligning our established, well-known supply chain solutions with Unilife's market-leading products and services to meet the long-term needs of pharmaceutical and biotechnology companies."

About Unilife Corporation

Unilife Corporation UNIS is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife's portfolio of innovative, differentiated products includes prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and novel systems. Products within each platform are customizable to address specific customer, drug and patient requirements. Unilife's global headquarters and manufacturing facilities are located in York, PA. For more information, visit www.unilife.com or download the Unilife IRapp on your iPhone, iPad or Android device.

General: UNIS-G

About Flextronics
Flextronics is a leading end-to-end supply chain solutions company that delivers design, engineering, manufacturing and logistics services to a range of industries and end-markets, including data networking, telecom, enterprise computing and storage, industrial, capital equipment, appliances, automation, medical, automotive, aerospace and defense, energy, mobile, computing and other electronic product categories. Flextronics is an industry leader with more than $26 billion in annualized sales, generated from helping its customers design, build, ship, and service their products through an unparalleled network of facilities and innovation centers in more than 30 countries and across four continents. Flextronics' service offerings and vertically integrated component technologies optimize customer supply chains by lowering costs, reducing supply chain risk, increasing flexibility, and reducing time-to-market. For more information, visit www.flextronics.com or follow us on Twitter @Flextronics.

Forward-Looking Statements

This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission. 

SOURCE Flextronics; Unilife Corporation